Browsing MED_Articles by Source "Medwave 2018 May-Jun.,18(3)"
Now showing items 1-1 of 1
-
Cost-effectiveness of lenalidomide in combination with dexamethasone compared to bortezomib in combination with dexamethasone for the second-line treatment of multiple myeloma in Chile
Medwave Estudios Limitada (2018)BACKGROUND Multiple myeloma is a hematologic malignancy affecting bone marrow derived plasma cells. Current therapies are not able to eradicate the disease and most patients become refractory to the treatment. Lenalidomide ...